Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 759 | 2003 |
AKT activation predicts outcome in breast cancer patients treated with tamoxifen T Kirkegaard, CJ Witton, LM McGlynn, SM Tovey, B Dunne, A Lyon, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 346 | 2005 |
Gene amplifications associated with the development of hormone-resistant prostate cancer J Edwards, NS Krishna, CJ Witton, JMS Bartlett Clinical cancer research 9 (14), 5271-5281, 2003 | 262 | 2003 |
Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling SM Tovey, CJ Witton, JMS Bartlett, PD Stanton, JR Reeves, TG Cooke Breast Cancer Research 6, 1-6, 2004 | 190 | 2004 |
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer? S Tovey, B Dunne, CJ Witton, A Forsyth, TG Cooke, JMS Bartlett Clinical cancer research 11 (13), 4835-4842, 2005 | 181 | 2005 |
Is PTEN loss associated with clinical outcome measures in human prostate cancer? P McCall, CJ Witton, S Grimsley, KV Nielsen, J Edwards British journal of cancer 99 (8), 1296-1301, 2008 | 179 | 2008 |
Tavassoli FA, Devilee P: Pathology and Genetics: Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours series-volume IV. Lyon, France: IARC Press: 2003 … AM Hanby, C Walker Breast Cancer Research 6, 1-2, 2004 | 149* | 2004 |
Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER‐negative, but not ER‐positive, breast cancer CJ Witton, SJK Hawe, TG Cooke, JMS Bartlett Histopathology 45 (1), 47-54, 2004 | 113 | 2004 |
Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH T Kirkegaard, CJ Witton, J Edwards, KV Nielsen, LB Jensen, ... Histopathology 56 (2), 203-211, 2010 | 71 | 2010 |
A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-fixed Paraffin Embedded Human Breast Tissue PJ Carder, CE Murphy, P Dervan, M Kennedy, A McCann, PTK Saunders, ... Breast cancer research and treatment 92, 287-293, 2005 | 63 | 2005 |
HER4 in breast cancer: comparison of antibodies against intra-and extra-cellular domains of HER4 SM Tovey, B Dunne, CJ Witton, TG Cooke, JMS Bartlett Breast cancer research 8, 1-8, 2006 | 43 | 2006 |
Frequent amplifications and deletions of G 1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G 1/S escape LB Jensen, JMS Bartlett, CJ Witton, T Kirkegaard, S Brown, S Müller, ... Cancer Biomarkers 5 (1), 41-49, 2009 | 27 | 2009 |
Structure of HER receptors and intracellular localisation of downstream effector elements gives insight into mechanism of tumour growth promotion CJ Witton Breast Cancer Research 5, 1-2, 2003 | 20 | 2003 |
Determining sensitivity to rapamycin and its analogues in breast cancer patients CJ Witton Breast Cancer Research 7, 1-2, 2004 | 10 | 2004 |
Injection of a boar sperm factor causes calcium oscillations in oocytes of the marsupial opossum, Monodelphis domestica CJ Witton, K Swann, J Carroll, HDM Moore Zygote 7 (4), 271-277, 1999 | 9 | 1999 |
Coexpression of EGFr, HER2, HER3 and HER4 in primary human breast carcinoma CJ Witton, JR Reeves, JG Going, TG Cooke, JMS Bartlett European Journal of Cancer 37 (S5), 21-22, 2001 | 5 | 2001 |
Predictive gene expression profile of breast cancer patients treated with tamoxifen MB Lyng, AV Lænkholm, W Vach, N Pallisgaard, A Knoop, H Ditzel | 2 | 2007 |
Analysis of HER2 status in breast cancer: a multicentre comparison of automated image analysis systems versus manual assessment JMS Bartlett, IO Ellis, EA Mallon Breast Cancer Res Treat 69, 401, 2001 | 2 | 2001 |
HER expression and breast cancer survival CJ Witton, JR Reeves, JJ Going, TG Cooke, J Bartlett The Journal of Pathology 200 (3), 290-297, 2003 | 1 | 2003 |
8th Nottingham International Breast Cancer Conference, Nottingham, UK, 16–19 September 2003 JL Limer, AT Parkes, A Waterworth, CE Murphy, CR Tait, CJ Witton Breast Cancer Research 6, 1-5, 2003 | 1 | 2003 |